ANDA User Fee Misses Are Mostly Part Of 'Imminent Approval' Process

 
• By Derrick Gingery
  
Generics
The FDA may miss an ANDA goal date if it could mean a issuing a full approval instead of a complete response. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards